Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Zoledronic Acid 5 mg/100ml solution for infusion

Active Ingredient:
zoledronic acid monohydrate
Company:  
Seacross Pharmaceuticals Ltd See contact details
ATC code: 
M05BA08
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

DOCTOR'S INFORMATION GUIDE

This information is part of the Risk Management Plan (RMP) for Zoledronic acid Seacross 5mg/100ml solution for infusion (hereafter refers as Zoledronic acid Seacross 5mg/100ml), and aims at minimisation of identified and potential therapy-related risks in order to optimize the benefit/risk balance. For complete information read the registered Summary of Product Characteristics of Zoledronic acid Seacross 5 mg/100ml before you prescribe Zoledronic acid Seacross 5mg/100ml.

{pdf_link}

PATIENT INFORMATION GUIDE

This brochure is intended for patients with an increased risk of bone fractures that are going to be treated with Zoledronic acid Seacross 5mg/100ml solution for infusion(Hereafter refer as Zoledronic acid Seacross 5mg/100ml). Read this brochure carefully because it gives you important information about Zoledronic acid Seacross 5mg/100ml. Please also read the package leaflet ofZoledronic acid Seacross 5mg/100ml for more information.

{pdf_link}

PATIENT REMINDER CARD

This reminder card contains important safety information that you need to be aware of before and during treatment with Zoledronic acid Seacross 5mg/100ml solution for infusion.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Seacross Pharmaceuticals Ltd
Company image
Address
Stanmore Place, Honeypot Lane, Stanmore, London, HA7 1BT
WWW
http://www.seacrosspharma.com
Telephone
+44 (0208 731 5273
Fax
+44 (0)203 727 0712
Medical Information Direct Line
+44 (0)208 731 5273
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0)208 731 5273
Medical Information Fax
+44 (0)203 727 0712